Bladder Cancer Updates

Recent FDA approvals of drugs like enforte map, pembrolizumab, and nivoleumab for metastatic urothelial cancer. Positive outcomes seen in the EV302 study with Fort Tumab Vadot and Pembrolizumab combination therapy. Exploration of new treatments in bladder cancer, including immune checkpoint inhibitors. Revolutionizing treatment for metastatic bladder cancer with high complete response rates and improved overall survival compared to traditional chemotherapy.